Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soumya Basu

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Plos One|June 29, 2010
Targeting mitochondrial cell death pathway to overcome drug resistance with a newly developed iron chelateAvishek Ganguly, Soumya Basu, Paramita Chakraborty, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 5, 2016
Curcumin and Ellagic acid synergistically induce ROS generation, DNA damage, p53 accumulation and apoptosis in HeLa cervical carcinoma cellsDevbrat Kumar, Soumya Basu, Lucy Parija, et al.
Data in Brief|April 28, 2022
Datasets comprising the quality validations of simulated protein-ligand complexes and SYBYL docking scores of bioactive natural compounds as inhibitors of <i>Mycobacterium tuberculosis</i> protein-targetsSravan Kumar Miryala, Soumya Basu, Aniket Naha, et al.
Molecular Diversity|December 21, 2022
Exploring binding mode assessment of novel kaempferol, resveratrol, and quercetin derivatives with PPAR-α as potent drug candidates against cancerSangeeta Ballav, Kiran Bharat Lokhande, Rohit Singh Yadav, et al.
Molecular Biosystems|March 17, 2011
Redox active copper chelate overcomes multidrug resistance in T-lymphoblastic leukemia cell by triggering apoptosisAvishek Ganguly, Soumya Basu, Kaushik Banerjee, et al.
Journal of Biomolecular Structure & Dynamics|July 12, 2022
Synergistic combination of ritonavir and cisplatin as an efficacious therapy in human cervical cancer cells: a computational drug discovery and <i>in vitro</i> insightDayanand Swami, Priyanka Mudaliar, Yash Shrinivas Bichu, et al.
Cancers|August 12, 2023
Non-Coding RNAs in Oral Cancer: Emerging Roles and Clinical ApplicationsSaurabh Dey, Bini Biswas, Angela Manoj Appadan, et al.
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|September 15, 2011
Iron N-(2-hydroxy acetophenone) glycinate (FeNG), a non-toxic glutathione depletor circumvents doxorubicin resistance in Ehrlich ascites carcinoma cells in vivoAvishek Ganguly, Paramita Chakraborty, Kaushik Banerjee, et al.
Biochimie|November 1, 2011
Targeting the mitochondrial pathway to induce apoptosis/necrosis through ROS by a newly developed Schiff's base to overcome MDR in cancerSoumya Basu, Avishek Ganguly, Paramita Chakraborty, et al.
Frontiers in Cellular and Infection Microbiology|September 30, 2021
Aerobactin Seems To Be a Promising Marker Compared With Unstable RmpA2 for the Identification of Hypervirulent Carbapenem-Resistant <i>Klebsiella pneumoniae</i>: <i>In Silico</i> and <i>In Vitro</i> EvidenceChaitra Shankar, Soumya Basu, Binesh Lal, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Plos One|June 29, 2010
Targeting mitochondrial cell death pathway to overcome drug resistance with a newly developed iron chelateAvishek Ganguly, Soumya Basu, Paramita Chakraborty, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 5, 2016
Curcumin and Ellagic acid synergistically induce ROS generation, DNA damage, p53 accumulation and apoptosis in HeLa cervical carcinoma cellsDevbrat Kumar, Soumya Basu, Lucy Parija, et al.
Data in Brief|April 28, 2022
Datasets comprising the quality validations of simulated protein-ligand complexes and SYBYL docking scores of bioactive natural compounds as inhibitors of <i>Mycobacterium tuberculosis</i> protein-targetsSravan Kumar Miryala, Soumya Basu, Aniket Naha, et al.
Molecular Diversity|December 21, 2022
Exploring binding mode assessment of novel kaempferol, resveratrol, and quercetin derivatives with PPAR-α as potent drug candidates against cancerSangeeta Ballav, Kiran Bharat Lokhande, Rohit Singh Yadav, et al.
Molecular Biosystems|March 17, 2011
Redox active copper chelate overcomes multidrug resistance in T-lymphoblastic leukemia cell by triggering apoptosisAvishek Ganguly, Soumya Basu, Kaushik Banerjee, et al.
Journal of Biomolecular Structure & Dynamics|July 12, 2022
Synergistic combination of ritonavir and cisplatin as an efficacious therapy in human cervical cancer cells: a computational drug discovery and <i>in vitro</i> insightDayanand Swami, Priyanka Mudaliar, Yash Shrinivas Bichu, et al.
Cancers|August 12, 2023
Non-Coding RNAs in Oral Cancer: Emerging Roles and Clinical ApplicationsSaurabh Dey, Bini Biswas, Angela Manoj Appadan, et al.
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|September 15, 2011
Iron N-(2-hydroxy acetophenone) glycinate (FeNG), a non-toxic glutathione depletor circumvents doxorubicin resistance in Ehrlich ascites carcinoma cells in vivoAvishek Ganguly, Paramita Chakraborty, Kaushik Banerjee, et al.
Biochimie|November 1, 2011
Targeting the mitochondrial pathway to induce apoptosis/necrosis through ROS by a newly developed Schiff's base to overcome MDR in cancerSoumya Basu, Avishek Ganguly, Paramita Chakraborty, et al.
Frontiers in Cellular and Infection Microbiology|September 30, 2021
Aerobactin Seems To Be a Promising Marker Compared With Unstable RmpA2 for the Identification of Hypervirulent Carbapenem-Resistant <i>Klebsiella pneumoniae</i>: <i>In Silico</i> and <i>In Vitro</i> EvidenceChaitra Shankar, Soumya Basu, Binesh Lal, et al.
Pageof 8